Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas bought 205,000 shares of the firm's stock in a transaction dated Wednesday, April 23rd. The stock was purchased at an average price of $0.40 per share, with a total value of $82,000.00. Following the completion of the purchase, the chief executive officer now directly owns 5,150,214 shares of the company's stock, valued at approximately $2,060,085.60. This trade represents a 4.15 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Monday, April 21st, Grigorios Siokas acquired 654,912 shares of Cosmos Health stock. The stock was purchased at an average price of $0.32 per share, for a total transaction of $209,571.84.
- On Monday, March 3rd, Grigorios Siokas bought 132,572 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.49 per share, for a total transaction of $64,960.28.
- On Monday, February 24th, Grigorios Siokas purchased 354,296 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.56 per share, with a total value of $198,405.76.
- On Thursday, January 30th, Grigorios Siokas acquired 51,414 shares of Cosmos Health stock. The shares were acquired at an average price of $0.66 per share, for a total transaction of $33,933.24.
Cosmos Health Stock Up 0.1 %
COSM stock opened at $0.40 on Friday. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. The firm has a 50 day simple moving average of $0.46 and a 200-day simple moving average of $0.63. The company has a market capitalization of $10.93 million, a P/E ratio of -0.16 and a beta of 5.50. Cosmos Health Inc. has a twelve month low of $0.28 and a twelve month high of $1.58.
Cosmos Health (NASDAQ:COSM - Get Free Report) last announced its quarterly earnings data on Tuesday, April 15th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.01. The company had revenue of $14.22 million during the quarter, compared to analyst estimates of $14.50 million. Cosmos Health had a negative net margin of 36.39% and a negative return on equity of 9.39%. On average, equities research analysts predict that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.
Institutional Trading of Cosmos Health
An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC grew its position in shares of Cosmos Health Inc. (NASDAQ:COSM - Free Report) by 29.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 193,432 shares of the company's stock after buying an additional 43,704 shares during the period. Geode Capital Management LLC owned about 0.83% of Cosmos Health worth $129,000 as of its most recent SEC filing. Institutional investors and hedge funds own 12.61% of the company's stock.
About Cosmos Health
(
Get Free Report)
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
